Paediatric homoeopathy in Germany: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).

Department of Epidemiology and Health Reporting, Division of Non-Communicable Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Pharmacoepidemiology and Drug Safety (Impact Factor: 2.9). 03/2009; 18(5):370-9. DOI: 10.1002/pds.1720
Source: PubMed

ABSTRACT Despite growing pressure against homoeopathy, an unexpected resurgence in the use of homoeopathy has been reported. It is of interest to examine the use of homoeopathy and user profiles among children in Germany.
Last-week homoeopathy use was recorded among 17,450 children aged 0-17 years who participated in the 2003-2006 German Health Interview and Examination Survey for Children and Adolescents (KiGGS). The complex sample method was used to estimate the prevalence of, and factors associated with, homoeopathy use.
Nine hundred and fifty-one homoeopathic preparations were used by 718 children (weighted prevalence 4.6%). Nearly half of the homoeopathic preparations were obtained by prescriptions from medical doctors or Heilpraktiker (non-medical practitioners) and used most often to treat certain self-limiting conditions. About 60% of homoeopathy users concomitantly received conventional medicines. Homoeopathy use was closely related to socioeconomic factors, with a significantly higher prevalence rate found in the 0-6 year age group [prevalence 6.2%, odds ratio 2.2, 95% confidence intervals (CIs) 1.7-2.9], among children residing in the former West Germany [5.1%, 2.2(1.5-3.2)] or the south of Germany [6.6%, 1.7(1.3-2.4)], among children with a poor health status [6.8%, 3.0(2.2-4.2)], with no immigration background [5.3%, 3.7(2.2-6.1)], who received breast-feeding >6 months [7.6%, 2.1(1.6-2.9)], were from upper social-class families [7.4%, 1.8(1.1-2.8)] and whose children's mothers were college educated [7.2%, 1.6(1.2-2.2)].
Paediatric homoeopathy is quite popular in Germany, particularly among children from families with a higher socioeconomic status. The high level of paediatric homoeopathy use in Germany warrants a critical review to determine whether it is evidence based and cost-effective.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Homeopathy is a form of therapy based on the similarity (“similia similibus curantur”, like cures like), whose popularity is increasing but whose scientific basis is still under discussion. Starting from the premise that it is a “holistic” medicine, programmatically aimed at the whole person in its entirety and individuality, here we go through an overview of his history, basic concepts and scientific evidence. This therapy was founded by Samuel Hahnemann in the late 18th century, although similar concepts existed previously. It has spread around the world in the 19th century, in part because of its success in epidemics outbreaks, but declined during most of the 20th century. Its popularity was increased in the late 20th and early 21st century in many parts of the world and today stands the problem of its integration with conventional medicine. There are different schools of homeopathy. Homeopathy is controversial mainly because of its use of highly diluted medicines, but there is growing evidence that is not a mere placebo. There is a significant body of clinical research including randomized clinical trials suggesting that homeopathy has an effectiveness in curing many symptoms and in improving the quality of life of patients. Cohort studies, observational and economic have produced favorable results. Despite the long history of scientific controversy, homeopathy is an “anomaly” of modern medicine that deserves further investigation for its potential scientific and ethical merits.
    Journal of Medicine and the Person. 12/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Incidence of invasive meningococcal disease is low in Germany at 0.5 cases/100,000 inhabitants. Serogroup B (MenB) is most common, causing 70% of cases, with highest incidence in infants (5.9/100,000). In 2013, a MenB vaccine was licensed in Europe. To assess pediatricians’ attitudes towards MenB vaccination and its potential use in Germany we conducted a nationwide cross-sectional survey among 5677 pediatricians. Of 3107 participants (response: 55%), 79.1% would recommend a MenB vaccination to parents, with 66.7% favoring a schedule at 6, 8 and 12 months over 2, 3, 4 and 12 months (13.4%). Administration separately from other vaccines was preferred (63.2%); 38.5% feared that a recommendation would lead to refusal of other recommended vaccinations. In conclusion, pediatricians showed distinct preferences regarding possible integration of MenB vaccination into the existent immunization schedule. As physicians play a crucial role in the implementation, findings will be useful in decision-making regarding potential introduction.
    Vaccine 09/2014; · 3.49 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We aimed to quantify progress towards measles elimination in Germany from 2007 to 2011 and to estimate any potential underreporting over this period.
    Bulletin of the World Health Organisation 10/2014; 92(10):742-9. · 5.11 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014